Mirae Asset Global Investments Co., Ltd. Vanda Pharmaceuticals Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,277 shares of VNDA stock, worth $11,999. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,277
Previous 1,951
16.71%
Holding current value
$11,999
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VNDA
# of Institutions
151Shares Held
45.3MCall Options Held
20KPut Options Held
999K-
Black Rock Inc. New York, NY8.14MShares$42.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.57MShares$18.8 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.45MShares$18.2 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.12MShares$16.4 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$13.6 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $298M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...